Aerospace Group:

Homeland Security

Cleveland BioLabs Completes Manufacturing Process for Radiation Drug

DDN

Wednesday, October 31st, 2007

SHARE:

Cleveland BioLabs [CBLI] has completed the technology transfer to its manufacturing partner for Protectan CBLB502, which the company has developed for medical radiation countermeasures to treat gastrointestinal effects of acute radiation syndrome. Production of the first Good Manufacturing Practices compliant batch of Protectan was also completed ahead of schedule. Cleveland BioLabs submitted Protectan in response to a Defense Department Request for Proposals. A contract would provide funding for development of the countermeasure through approval by the Food and Drug Administration,…

Congress

Pentagon Fiscal 2027 Budget To Address Cannibalization Of Parts For F-35, Legislator Says

The Pentagon’s upcoming fiscal 2027 budget request will help reduce the cannibalization of parts for the F-35 fighter by Lockheed Martin [LMT], the chairman of the House Armed Services Committee’s […]

Budget

Trump’s $1.15 Trillion Request For DoD Is The ‘New Normal,” HASC Chairman Says

COLORADO SPRINGS, Colo.—The Trump administration’s nearly $1.2 trillion baseline defense budget request for fiscal year 2027 will be adopted and will be the foundation for the “new normal” going forward, […]

Congress

Trump Wants Second Reconciliation Bill On His Desk By June 1

President Donald Trump on Wednesday called on Congress to pass and send a second reconciliation bill to his desk by June 1. The deadline follows congressional Republicans’ backing a pursuit […]

Space

Upgrading Current GPS Ground System “Now a Viable Option,” As GPS OCX Problems Continue, Space Official Says

Upgrades to the GPS ground system–the Architecture Evolution Plan (AEP)–is an option under consideration by the Defense Department’s space acquisition chief, as problems continue in fielding the GPS Next Generation […]